首页 | 本学科首页   官方微博 | 高级检索  
检索        

CysLT2受体拮抗剂HAMI3379抑制LPS诱导小鼠小胶质瘤细胞系的炎性反应
引用本文:顾胜龙,李明星,应苗法,方三华,饶跃峰,赵蕊.CysLT2受体拮抗剂HAMI3379抑制LPS诱导小鼠小胶质瘤细胞系的炎性反应[J].基础医学与临床,2020,40(2):145-150.
作者姓名:顾胜龙  李明星  应苗法  方三华  饶跃峰  赵蕊
作者单位:浙江大学医学院附属邵逸夫医院 药剂科,浙江 杭州310016;浙江大学医学院 公共技术平台,浙江 杭州310058;浙江大学医学院附属第一医院 药剂科,浙江 杭州310003
基金项目:国家自然科学基金;浙江省公益性技术应用研究计划;浙江省自然科学基金
摘    要:目的探究半胱氨酰白三烯2(CysLT2)受体拮抗剂HAMI3379对LPS诱导小鼠小胶质细胞(BV-2)炎性反应的调控作用及其可能的作用机制。方法体外培养BV-2,将BV-2分为对照组、LPS(100 ng/mL)组、HAMI3379(0.01、0.1和1μmol/mL)组和LPS+HAMI3379组。CCK-8法检测BV-2细胞的增殖;ELISA检测细胞上清液中炎性因子IL-1β、TNF-α、IL-10的含量;Western-blot检测PKCα、IKBα、NF-κB p50和p65蛋白的表达。结果LPS能够激活BV-2细胞,促进其细胞的增殖(P<0.05);显著增加细胞上清液中炎性因子IL-1β、TNF-α的分泌,减少IL-10的分泌(P<0.05);且显著上调PKCα、IKBα、p65蛋白的表达水平(P<0.05)。CysLT2受体拮抗剂HAMI3379能够显著减轻上述变化(P<0.05)。结论CysLT2受体拮抗剂HAMI3379能够抑制LPS激活BV-2细胞,抑制炎性反应,其作用机制可能与抑制PKCα/NF-κB信号通路有关。

关 键 词:CysLT2受体  HAMI3379  炎性反应  PKCα/NF-κB信号通路

CysLT2 receptor antagonist HAMI3379 inhibits LPS-induced inflammation in mice microglia line BV-2
GU Sheng-long,LI Ming-xing,YING Miao-fa,FANG San-hua,RAO Yue-feng,ZHAO Rui.CysLT2 receptor antagonist HAMI3379 inhibits LPS-induced inflammation in mice microglia line BV-2[J].Basic Medical Sciences and Clinics,2020,40(2):145-150.
Authors:GU Sheng-long  LI Ming-xing  YING Miao-fa  FANG San-hua  RAO Yue-feng  ZHAO Rui
Institution:(Department of Pharmacy,Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University,Hangzhou 310016;Core Facilities,School of Medicine,Zhejiang University,Hangzhou 310058;Department of Pharmacy,the first Affiliated Hospital,Zhejiang University,Hangzhou 310003,China)
Abstract:Objective To investigate the role and possible mechanism of CysLT2 receptor antagonist HAMI3379 on the inflammatory response of mouse microglia(BV-2)induced by LPS.Methods BV-2 cells were divided into control group,LPS(100 ng/mL)group,HAMI3379(0.01,0.1 and 1μmol/mL)group and LPS+HAMI3379 group.The proliferation of BV-2 cells was detected by CCK-8 assay.The contents of cytokines IL-1β,TNF-αand IL-10 were measured by ELISA assay.Western blot was used to detect the expression of PKCα,IKBα,NF-κB p50 and p65 protein.Results LPS significantly induced the activation of BV-2 cells and promoted proliferation of cells(P<0.05).The secretion of inflammatory factors IL-1βand TNF-αwas significantly increased and the secretion of IL-10 was obviously reduced in cell supernatant(P<0.05).The expression of PKCα,IKBαand p65 proteins were significantly up-regulated(P<0.05).The CysLT2 receptor antagonist HAMI3379 was able to reduce these changes.Conclusions The CysLT2 receptor antagonist HAMI3379 may inhibit the activation of BV-2 cells induced by LPS and reduce the inflammatory response,and the possible mechanism is related to the inhibition of PKCα/NF-κB signaling pathway.
Keywords:CysLT2 receptor  HAMI3379  inflammation  PKCα/NF-κB signaling pathway
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号